论文部分内容阅读
芬氟拉明(fenfluramine)是由上海医药工业研究院试制成功,并由该院制药厂制成盐酸盐片剂(每片含20mg),经由上海瑞金医院保健科、上海内分泌研究所及上海市第二、四、六人民医院内科5个临床单位对52例单纯性肥胖症患者进行了临床验证,于1984年5月3日由上海市卫生局药政处在上海召开鉴定会议,有以上各单位及上海市药检所、上海市医药公司新药科参加会议。
Fenfluramine was successfully trial-produced by Shanghai Institute of Pharmaceutical Industry and was made into hydrochloride tablet (20mg per tablet) by Shanghai Pharmaceutical Industry Research Institute. Through Shanghai Ruijin Hospital Department of Health, Shanghai Institute of Endocrinology and Shanghai City Second, Fourth, Six People’s Hospital, five clinical units of 52 cases of simple obesity clinical validation, on May 3, 1984 by the Shanghai Municipal Health Bureau Pharmaceutical Administration held an appraisal meeting in Shanghai, with the above All units and the Shanghai Drug Prosecution, Shanghai Pharmaceutical Company New Drugs attended the meeting.